CNS & Neurological Disorders - Drug Targets
Title:In memory of Prof. Stephen Drake Skaper
Volume: 17 Issue: 5
Author(s): Cinzia Volonte
Affiliation:
Export Options
About this article
Cite this article as:
Volonte Cinzia , In memory of Prof. Stephen Drake Skaper, CNS & Neurological Disorders - Drug Targets 2018; 17 (5) . https://dx.doi.org/10.2174/187152731705180807144910
DOI https://dx.doi.org/10.2174/187152731705180807144910 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
21
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology β-Amyloid, Cholinergic Transmission, and Cerebrovascular System - A Developmental Study in a Mouse Model of Alzheimer's Disease
Current Pharmaceutical Design Depleted Uranium and Human Health
Current Medicinal Chemistry Highly Active Antiretroviral Therapy-Induced Liver Injury
Current Drug Safety Deep Learning in Disease Diagnosis: Models and Datasets
Current Bioinformatics The Chemokine CXCL10 as a Therapeutic Target in Animal Models of Neuroinflammatory Disease
Letters in Drug Design & Discovery In Silico Predictions of hERG Channel Blockers in Drug Discovery: From Ligand-Based and Target-Based Approaches to Systems Chemical Biology
Combinatorial Chemistry & High Throughput Screening Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology Cerium Oxide Nanoparticles Trigger Neuronal Survival in a Human Alzheimer Disease Model By Modulating BDNF Pathway
Current Nanoscience Wnt Signaling in Development, Disease and Translational Medicine
Current Drug Targets Hepatitis C Virus Clearance: The Enigma of Failure Despite an Impeccable Survival Strategy
Current Pharmaceutical Biotechnology Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems
Current Drug Targets Evaluation of In Vivo and In Vitro Antimicrobial Activities of a Selective Serotonin Reuptake Inhibitor Sertraline Hydrochloride
Anti-Infective Agents Protein Misfolding and Aggregation in Alzheimer's Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimers Disease Mechanisms
Current Alzheimer Research Progress in Target Drug Molecules for Alzheimer's Disease
Current Topics in Medicinal Chemistry Pharmacological Overview and Future Perspectives of Cholinergic Therapy in Alzheimers Disease
Current Drug Therapy Editorial:
Current Immunology Reviews (Discontinued) The Role of Annexin A1 and Formyl Peptide Receptor 2/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory
CNS & Neurological Disorders - Drug Targets Hurdles in the Drug Discovery of Cathepsin K Inhibitors
Current Topics in Medicinal Chemistry